World-class
Scientific Advisory

Work with Richmond Pharmacology and trust your experience will be personal and truly strategic.

Dr T.J Von Oertzen - Consultant Neurologist and Epileptologist (MD., F.R.C.P.)

Dr. von Oertzen studied medicine at Rheinische-Friedrich-Wilhelm University, Germany and completed his final year at University College of London in 1995. He was supervising consultant in Europe's largest centre for presurgical evaluation in epilepsy, Department of Epileptology, at the University of Bonn where he gained major experience in all aspects of blackouts, epilepsy, non epileptic attack disorders and other conditions. Dr. von Oertzen is fully trained in Neurophysiology, particularly in EEG (electroencephalogram recording of brainwaves) of both surface and intracranial recordings.

Dr. von Oertzen has been appointed as the lead clinician for the epilepsy service at the Atkinson Morley Neuroscience Centre, St George's Hospital, since 2004. At present, he is holding specialist clinics for first fits and blackouts, complex cases and people with drug refractory epilepsy including pre-surgical assessment. He holds an Honorary Senior Lecturer post at St George's University of London is also honorary Consultant Neurologist at Kingston Hospital.

Dr. von Oertzen has presented clinical and research data on national and international conferences. He has frequently published in medical journals and contributed to definite books about epilepsy. He is involved in raising awareness for epilepsy and providing continuous medical education for medical professionals.

Back to experts

Latest news

Upcoming Event

EUFEMED, 3rd Annual Conference, 28-30 April 2021

28-30 April 2021
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
View event

Richmond Pharmacology listed in the Alantra Pharma Fast 50

July 13, 2021
Richmond has been included in a top 50 list of the UK’s fastest-growing, privately-owned pharmaceutical businesses. 
Read more

Richmond Pharmacology listed in the J.P. Morgan Top 200 Female Powered Businesses

June 29, 2021
J.P. Morgan has identified Richmond Pharmacology as a high-growth female-powered business in its annual 'Top 200 Female Powered Businesses' list 2021.
Read more

CRISPR-Cas9 in-vivo gene editing shows reduction in TTR after a single dose

June 29, 2021
Data produced through Intellia Therapeutic’s NTLA-2001 FIH clinical trial, conducted at Richmond Pharmacology, indicates a reduction in the faulty TTR protein after a single infusion. Results were presented by Professor Julian Gillmore at this year’s Peripheral Nerve Society Annual Meeting.
Read more